Vensana Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals
  • Investments
  • 12

  • Portfolio
  • 10

  • Exits
  • 4

Exits

Vensana Capital General Information

Description

Founded in 2019, Vensana Capital is a venture capital and growth equity investment firm based in Minneapolis, Minnesota. The firm seeks to invest in companies operating in the medical devices, diagnostics and data science, drug delivery, digital health, life science tools and tech-enabled services sectors.

Contact Information

Year Founded
2019
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 3601 West 76th Street
  • Suite 20
  • Minneapolis, MN 55435
  • United States
+1 (612) 000-0000

Vensana Capital Investments (12)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ChromaCode 03-Mar-2022 Later Stage VC 0000 Diagnostic Equipment Generating Revenue
000000 (00000 0000 22-Dec-2021 00000 00000 000.00 Other Healthcare Technology Systems Startup 000000 00000 00
0000000 21-Jun-2021 00000 00000 0000 Decision/Risk Analysis Generating Revenue 000000 00000 00
000000 00000000000 23-Apr-2021 00000 00000 0000 Biotechnology Product Development 000000 00000 00
00000000 000000 00 10-Feb-2021 00000 00000 00000 Discovery Tools (Healthcare) Generating Revenue 000000 00000 00
00000000 000000000 11-Jan-2021 00000 00000 000.00 Other Devices and Supplies Startup 0000 0000000
000000000 0000000 05-Nov-2020 00000 00000 0000 Therapeutic Devices Clinical Trials - Phase 2 0000 0000000
000000000 00000000 29-Oct-2020 00000 00000 000.00 Surgical Devices Generating Revenue 000000 00000 00
CVRx 07-Jul-2020 Later Stage VC 0000 Therapeutic Devices Generating Revenue/Not Profitable 0000 0000000
Intact Vascular 05-May-2020 Later Stage VC 000.00 Other Devices and Supplies Generating Revenue 000000 00000 00
You’re viewing 10 of 12 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vensana Capital Exits (4)

Company Name Exit Date Exit Type Exit Size
Personal Genome Diagnostics 21-Feb-2022 Merger/Acquisition 00000
0000 30-Jun-2021 000 00000
000000 00000000 04-Sep-2020 000000000000000000 00000
You’re viewing 3 of 4 exits. Get the full list »

Vensana Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Vensana Capital‘s full profile, request access.

Request a free trial

Vensana Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Vensana Capital Team (34)

Name Title Deals Funds Boards Office
Justin Klein MD Co-Founder & Managing Partner 00 0 0 Minneapolis, MN
Cynthia Yee Principal 0 Minneapolis, MN
Greg Banker MD Vice President Minneapolis, MN
Leslie Trigg Advisor Minneapolis, MN
Nadim Yared Advisor Minneapolis, MN
You’re viewing 5 of 34 team members. Get the full list »

Vensana Capital Co-Investors (36)

Name With Exits Lead Partner Series Industry
New Enterprise Associates 6 0 0 Series chart Industry bar
Gilde Healthcare Partners 0 0 0 Series chart Industry bar
PFM Health Sciences 0 0 0 Series chart Industry bar
Quaker Partners 0 0 0 Series chart Industry bar
Morgenthaler Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 36 co-investors. Get the full list »